XML 21 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Shareholders' Equity - USD ($)
Total
Common Shares
Deferred Equity Compensation
Retained Earnings
Beginning Balance (in shares) at Dec. 31, 2021   3,171,536    
Beginning Balance at Dec. 31, 2021 $ 184,422,902 $ 80,434,049 $ (15,268,705) $ 119,257,558
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of restricted stock grants (in shares)   76,143    
Issuance of restricted share grants   $ 13,436,439 (13,436,439)  
Amortization of restricted share grants 10,530,486   10,530,486  
Issuance of stock grants (in shares)   2,743    
Common shares issued as incentive compensation 487,870 $ 487,870    
Issuance of common stock related to 401k plan match (in shares)   211    
Issuance of common shares related to 401(k) plan match 37,313 $ 37,313    
Issuance of common stock related to employee stock purchase plan (shares)   3,392    
Issuance of common shares related to employee stock purchase plan 619,159 $ 619,159    
Shares withheld related to employee tax withholding (shares)   (19,302)    
Shares withheld related to employee tax withholding obligations (3,436,678) $ (3,436,678)    
Forfeiture of restricted stock grants (in shares)   (7,257)    
Forfeiture of restricted share grants   $ (1,163,514) 1,163,514  
Repurchases of common stock (in shares)   (217,009)    
Repurchases of common shares (38,726,007) $ (38,726,007)    
Cash dividend paid of $6.00 in 2016, $7.00 in 2017, and $8.00 in 2018 per share respectively (30,696,907)     (30,696,907)
Net income attributable to parent 40,434,107     40,434,107
Ending Balance (in shares) at Dec. 31, 2022   3,010,457    
Ending Balance at Dec. 31, 2022 163,672,245 $ 51,688,631 (17,011,144) 128,994,758
Beginning balances attributable to redeemable noncontrolling interests at Dec. 31, 2021 17,756,336      
Increase (Decrease) in Temporary Equity [Roll Forward]        
Net (loss) income attributable to redeemable noncontrolling interests (3,563,345)      
Net subscriptions of consolidated funds 9,461,710      
Net deconsolidations of Company sponsored investments (9,528,503)      
Ending balances attributable to redeemable noncontrolling interests at Dec. 31, 2022 14,126,198      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of restricted stock grants (in shares)   59,578    
Issuance of restricted share grants   $ 11,131,853 (11,131,853)  
Amortization of restricted share grants 11,603,239   11,603,239  
Issuance of stock grants (in shares)   0    
Common shares issued as incentive compensation 0 $ 0    
Issuance of common stock related to 401k plan match (in shares)   99    
Issuance of common shares related to 401(k) plan match 16,344 $ 16,344    
Issuance of common stock related to employee stock purchase plan (shares)   2,904    
Issuance of common shares related to employee stock purchase plan 482,097 $ 482,097    
Shares withheld related to employee tax withholding (shares)   (30,204)    
Shares withheld related to employee tax withholding obligations (5,131,262) $ (5,131,262)    
Forfeiture of restricted stock grants (in shares)   (7,120)    
Forfeiture of restricted share grants 0 $ (1,147,340) 1,147,340  
Repurchases of common stock (in shares)   (212,638)    
Repurchases of common shares (34,875,913) $ (34,875,913)    
Cash dividend paid of $6.00 in 2016, $7.00 in 2017, and $8.00 in 2018 per share respectively (17,676,364)     (17,676,364)
Net income attributable to parent $ 42,226,422     42,226,422
Ending Balance (in shares) at Dec. 31, 2023 2,823,076 2,823,076    
Ending Balance at Dec. 31, 2023 $ 160,316,808 $ 22,164,410 (15,392,418) 153,544,816
Increase (Decrease) in Temporary Equity [Roll Forward]        
Net (loss) income attributable to redeemable noncontrolling interests 859,126      
Net subscriptions of consolidated funds 10,350,857      
Net deconsolidations of Company sponsored investments (25,336,181)      
Ending balances attributable to redeemable noncontrolling interests at Dec. 31, 2023 0      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of restricted stock grants (in shares)   87,344    
Issuance of restricted share grants   $ 13,474,536 (13,474,536)  
Amortization of restricted share grants 11,763,736   11,763,736  
Issuance of stock grants (in shares)   0    
Common shares issued as incentive compensation 0 $ 0    
Issuance of common stock related to employee stock purchase plan (shares)   2,501    
Issuance of common shares related to employee stock purchase plan 385,037 $ 385,037    
Shares withheld related to employee tax withholding (shares)   (39,757)    
Shares withheld related to employee tax withholding obligations (6,275,907) $ (6,275,907)    
Forfeiture of restricted stock grants (in shares)   (7,471)    
Forfeiture of restricted share grants   $ (1,269,561) 1,269,561  
Repurchases of common stock (in shares)   (195,224)    
Repurchases of common shares (30,520,599)     (30,520,599)
Cash dividend paid of $6.00 in 2016, $7.00 in 2017, and $8.00 in 2018 per share respectively (16,530,676)     (16,530,676)
Net income attributable to parent $ 43,177,729     43,177,729
Ending Balance (in shares) at Dec. 31, 2024 2,670,469 2,670,469    
Ending Balance at Dec. 31, 2024 $ 162,316,128 $ 28,478,515 $ (15,833,657) $ 149,671,270
Increase (Decrease) in Temporary Equity [Roll Forward]        
Net (loss) income attributable to redeemable noncontrolling interests 189      
Net subscriptions of consolidated funds 245,819      
Ending balances attributable to redeemable noncontrolling interests at Dec. 31, 2024 $ 246,008